ALIQOPA is a prescription medicine used to treat adults with follicular lymphoma (FL) when the disease has come back after treatment with at least two prior medicines. Active ingredient: copanlisib. Inactive ingredients: citric acid anhydrous, mannitol, sodium hydroxide

What is Copanlisib?

Copanlisib is a drug which is approved by US FDA for the treatment of adult patients experiencing relapsed follicular lymphoma who have received at least two prior systemic therapies. Copanlisib has been shown to have an effect against survival and spread of cancerous B-cells.

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand ALIQOPA (copanlisib) for injection) on prescription and Import License in Patient's Name only.

For Aliqopa Injection or generic Copanlisib in India. Please call at M: +91 9811747774 or Email Us to know more details about the medicine and its cost price in India.
ALIQOPA (copanlisib) for injection)

Get In Touch

Facilitator under Patient Assistance Programs In India

For Indian Patients, doctors and hospitals ALIQOPA (copanlisib) for injection) can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Dosage Forms and Strengths

For injection: 60 mg as a lyophilized solid in single-dose vial for reconstitution.